Sub Banner Image

ABBV's Improving Oncology Sales Poise It Well for Long-Term Growth

Equities

Zacks Investment Research

·

August 22, 2025

·

Barchart

AbbVie ABBV is known for its strong immunology franchise comprising blockbuster drugs like Skyrizi, Rinvoq and Humira. However, AbbVie has also built a substantial oncology franchise with products like Imbruvica and Venclexta.Some key oncology drugs approved in the past couple of years are AbbVie and partner Genmab’s Epkinly for relapsed...

More from

Barchart

More

Equities

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.